Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1973 6
1974 5
1975 16
1976 50
1977 86
1978 133
1979 173
1980 232
1981 180
1982 222
1983 327
1984 395
1985 431
1986 431
1987 424
1988 551
1989 552
1990 550
1991 525
1992 550
1993 562
1994 573
1995 540
1996 554
1997 461
1998 484
1999 371
2000 385
2001 307
2002 333
2003 288
2004 302
2005 235
2006 298
2007 288
2008 275
2009 224
2010 257
2011 219
2012 205
2013 242
2014 227
2015 198
2016 185
2017 180
2018 210
2019 214
2020 199
2021 203
2022 205
2023 204
2024 189
2025 204
2026 89

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,100 results

Results by year

Filters applied: . Clear all
Page 1
Increased Vasoactive Intestinal Peptide (VIP) in polycystic ovary syndrome patients undergoing IVF.
Sallicandro L, Gliozheni E, Feudi D, Sabbatini P, Pellegrino RM, Alabed HBR, Baldini D, Gerli S, Alviggi C, Cascardi E, Cicinelli E, Malvasi A, Fioretti B. Sallicandro L, et al. Front Endocrinol (Lausanne). 2024 May 7;15:1331282. doi: 10.3389/fendo.2024.1331282. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38774232 Free PMC article.
Follicular fluid (FF) represents an environment for the normal development of follicles rich in metabolites, hormones and neurotransmitters, but in some instances of PCOS the composition can be different. Vasoactive intestinal peptide (VIP) is an endog …
Follicular fluid (FF) represents an environment for the normal development of follicles rich in metabolites, hormones and neurotransmitters, …
Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery.
Klippstein R, Pozo D. Klippstein R, et al. Adv Protein Chem Struct Biol. 2015;98:145-68. doi: 10.1016/bs.apcsb.2014.11.006. Epub 2015 Mar 3. Adv Protein Chem Struct Biol. 2015. PMID: 25819279 Review.
However, the effective translation of preclinical studies related to VIP to clinical realities faces several major challenges, most of which are commonplace for other neuropeptides. Here, we present recent studies aimed at developing nanostructured organic and inorganic sy …
However, the effective translation of preclinical studies related to VIP to clinical realities faces several major challenges, most o …
Vasoactive intestinal peptide (VIP), a putative neurotransmitter of nonadrenergic, noncholinergic (NANC) inhibitory innervation and its relevance to therapy.
Venugopalan CS. Venugopalan CS. J Vet Pharmacol Ther. 1989 Jun;12(2):113-23. doi: 10.1111/j.1365-2885.1989.tb00652.x. J Vet Pharmacol Ther. 1989. PMID: 2568497 Review.
Although the neurotransmitter has not been conclusively identified, a substantial body of evidence exists to support vasoactive intestinal peptide (VIP) as the neurotransmitter. VIP is widely distributed in the body. ...An increase in VIP …
Although the neurotransmitter has not been conclusively identified, a substantial body of evidence exists to support vasoactive in …
Editorial: vasoactive intestinal peptide (vip): historic perspective and future potential.
Foster N. Foster N. Endocr Metab Immune Disord Drug Targets. 2012 Dec;12(4):303-7. doi: 10.2174/187153012803832521. Endocr Metab Immune Disord Drug Targets. 2012. PMID: 23094826
Numerous studies, since the late 1970s, have highlighted the role of vasoactive intestinal peptide (VIP) in the immune system of mammals. Importantly, these studies have show that VIP has an inhibitory effect on the production and action of many …
Numerous studies, since the late 1970s, have highlighted the role of vasoactive intestinal peptide (VIP) in the …
A new neuroregulator: the vasoactive intestinal peptide or VIP.
Rosselin G, Maletti M, Besson J, Rostène W. Rosselin G, et al. Mol Cell Endocrinol. 1982 Aug;27(3):243-62. doi: 10.1016/0303-7207(82)90092-2. Mol Cell Endocrinol. 1982. PMID: 6290287 Review.
The method used to demonstrate the involvement of VIP in a physiological regulation is described and illustrated by two examples: the effect of VIP on gut epithelium and the neuroendocrine action of VIP in inducing prolactin release from pituitary cells. The …
The method used to demonstrate the involvement of VIP in a physiological regulation is described and illustrated by two examples: the …
Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes.
Hou X, Yang D, Yang G, Li M, Zhang J, Zhang J, Zhang Y, Liu Y. Hou X, et al. Front Endocrinol (Lausanne). 2022 Sep 20;13:984198. doi: 10.3389/fendo.2022.984198. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36204104 Free PMC article. Review.
Owing to the increasing prevalence of type 2 diabetes, the development of novel hypoglycemic drugs has become a research hotspot, with the ultimate goal of developing therapeutic drugs that stimulate glucose-induced insulin secretion without inducing hypoglycemia. Vasoactive …
Owing to the increasing prevalence of type 2 diabetes, the development of novel hypoglycemic drugs has become a research hotspot, with the u …
Immunobiology of vasoactive intestinal peptide (VIP).
Pozo D, Delgado M, Martínez M, Guerrero JM, Leceta J, Gomariz RP, Calvo JR. Pozo D, et al. Immunol Today. 2000 Jan;21(1):7-11. doi: 10.1016/s0167-5699(99)01525-x. Immunol Today. 2000. PMID: 10637552 Review. No abstract available.
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications.
Onoue S, Misaka S, Yamada S. Onoue S, et al. Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):579-90. doi: 10.1007/s00210-007-0232-0. Epub 2008 Jan 3. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18172612 Review.
Vasoactive intestinal peptide (VIP) has been identified as one of major peptide transmitters in the central and peripheral nervous systems, being involved in a wide range of biological functions. ...Combination of the use of potent VIP an …
Vasoactive intestinal peptide (VIP) has been identified as one of major peptide transmitters in the centr …
Vasoactive intestinal peptide (VIP): an amnestic neuropeptide.
Flood JF, Garland JS, Morley JE. Flood JF, et al. Peptides. 1990 Sep-Oct;11(5):933-8. doi: 10.1016/0196-9781(90)90012-t. Peptides. 1990. PMID: 2178250
Vasoactive intestinal peptide (VIP) is a neuropeptide present in high concentrations in the hippocampus. ...Central administration of arecoline, but not neuropeptide Y, blocked the amnestic effect of VIP. It is concluded that VIP is a pot …
Vasoactive intestinal peptide (VIP) is a neuropeptide present in high concentrations in the hippocampus. ...Cent …
Vasoactive intestinal peptide axis is dysfunctional in patients with Graves' disease.
Carrión M, Ramos-Leví AM, Seoane IV, Martínez-Hernández R, Serrano-Somavilla A, Castro D, Juarranz Y, González-Álvaro I, Gomariz RP, Marazuela M. Carrión M, et al. Sci Rep. 2020 Aug 3;10(1):13018. doi: 10.1038/s41598-020-70138-3. Sci Rep. 2020. PMID: 32747757 Free PMC article.
Vasoactive intestinal peptide (VIP) is a neuropeptide with potent immunoregulatory properties. Reduced serum VIP levels and alterations in VIP receptors/signaling on immune cells have been associated with different inflammatory/autoimmune …
Vasoactive intestinal peptide (VIP) is a neuropeptide with potent immunoregulatory properties. Reduced serum …
15,100 results
You have reached the last available page of results. Please see the User Guide for more information.